7630 (7630) News
Follow 7630 (7630) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 3 public stories across 3 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Impact Therapeutics files Senaparib for EU final marketing authorization
Impact Therapeutics says Senaparib has been submitted to the European Commission for a final marketing authorization decision.
REGULATION | Sep 18, 2026, 03:37 PM UTC
L
Impact Therapeutics CEO buys 100,000 shares at HK$14.6105
Impact Therapeutics Inc CEO purchased 100,000 ordinary shares at HK$14.6105 per share, according to the HKEX 7630 listing.
EQUITY | Sep 03, 2026, 12:03 AM UTC
L
Yomiuri: House Foods Group Looks to Chop CoCo Ichibanya Curry Chain From Menu
Yomiuri: House Foods Group Looks to Chop CoCo Ichibanya Curry Chain From Menu
EQUITY | Sep 01, 2026, 06:57 AM UTC